Articles tagged with Hyperplasia
A cohort study found combined GLP-1RA and progestin therapy reduces endometrial cancer risk in women with benign uterine pathology or endometrial hyperplasia. The study suggests potential benefits of this treatment approach for nonmalignant uterine diseases.
A new study finds that a specific genetic variation in the PTGS2 gene is associated with an increased risk of benign prostate hyperplasia (BPH) in Lebanese men. Men carrying the C version of this gene were more than twice as likely to have BPH compared to those without it.
The WATER III trial shows that waterjet surgery can better preserve ejaculation function compared to standard laser surgery. The technique has similar outcomes and can be performed with robot assistance, reducing waiting times for men with urinary problems caused by an enlarged prostate.
A rare case of adenomyosis in an 81-year-old postmenopausal woman closely resembles invasive endometrial cancer, emphasizing the challenges of diagnosing this condition. Further studies are needed to refine diagnostic protocols and determine risk factors for postmenopausal patients.
A study found that pro-inflammatory molecules contribute to benign prostatic hyperplasia (BPH) in aging men, especially those with metabolic syndrome. Men with BPH had higher levels of pro-inflammatory markers and lower anti-inflammatory substances, suggesting a link between inflammation and prostate conditions.
A new study published in the New England Journal of Medicine found that crinecerfont reduces adrenal androgen production by half in adults with Congenital Adrenal Hyperplasia (CAH), allowing for lower doses of corticosteroids. This could lead to fewer long-term side effects associated with high-dose corticosteroid use.
A new study found that the gut microbiota plays a significant role in prostate inflammation in aging men, particularly those with metabolic syndrome. The researchers discovered a strong relationship between IL-6 and IL-18 expression and lipid parameters in the prostate tissue of men with BPH + MetS.
Researchers have created the first humanized mouse model for Congenital Adrenal Hyperplasia, a rare genetic disease affecting 1 in 15,000 births. The mouse model accurately mimics human symptoms and allows for testing of novel treatments and stem cell therapies.
Researchers discuss the importance of biomarkers in breast lump management, enabling patients to make informed decisions between proactive treatment and watchful waiting. The development of biomarkers could provide personalized risk assessments and guide treatment strategies for women with breast lumps.
A study of over 43,000 adults found that parathyroidectomy has no estimated effect on long-term kidney function in older adults. However, early treatment may preserve kidney function in patients younger than 60 years old.
A new trial shows that the novel surgical device venous external support (VEST) may improve outcomes of coronary bypass grafting using leg veins by preventing intimal hyperplasia, a key factor in vein graft failure.
Researchers developed a computer vision tool to analyze facial images of patients with congenital adrenal hyperplasia (CAH), revealing strong correlations between facial features and the condition. The study's findings could lead to improved phenotyping and treatment of CAH, a life-threatening genetic disorder affecting children.
A study found that e-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice. Exposure to e-cigarette juice led to a high incidence of tumors, while filtered air exposure had minimal effects.
A recent study of 100,000 Korean men found that low education level, household income, and social capital are associated with a higher risk of benign prostatic hyperplasia. The findings suggest that health programs based on community needs may help prevent BPH and improve quality of life for affected individuals.
Researchers report a higher incidence of PAH after cryolipolysis, with 15 events in 11 patients representing 0.72% of treatments, highlighting the need for caution and careful management when dealing with this complication.
Researchers at the University of Montreal Hospital Research Centre have identified a new syndrome in mice with deleted Armc5 gene, characterized by adrenal gland abnormalities and immune system compromise. The study opens up new avenues for understanding and treating diseases linked to the ARMC5 gene.
A new treatment option for benign prostatic hyperplasia (BPH) has been shown to improve patient symptoms regardless of prostate size. Prostate artery embolization (PAE) is a minimally invasive procedure that blocks blood flow to the enlarged gland, resulting in reduced risk of bleeding and urinary complications.
A Mayo Clinic study found that women with atypical hyperplasia have an increased risk of developing breast cancer over time. After five years, 7% had developed the disease, and after 10 years, 13%. The study suggests that these women should be considered high-risk and screened more intensively.
A study found that genetic testing can help identify BPH patients at higher risk of developing prostate cancer. Ten single nucleotide polymorphisms were linked to PCa risk, with one marker showing a strong association.
Spanish scientists have confirmed a clear relationship between androgenetic alopecia and benign prostate hyperplasia, with men experiencing premature baldness at higher risk for BPH. The study, published in the Journal of the American Academy of Dermatology, found an association between hormone levels and prostate volume.
A study published in Archives of Otolaryngology - Head & Neck Surgery found no evidence of Helicobacter pylori bacteria in enlarged adenoids of children. However, Candidatus Wolinella africanus was detected in one hyperplastic adenoid sample, suggesting occasional reflux episodes may contribute to the disease's pathophysiology.
Long-term finasteride use has been shown to reduce disease progression and improve urinary tract symptoms associated with benign prostatic hyperplasia. The treatment also reduces the risk of acute urinary retention and surgical intervention, making it an effective option for men with moderate to severe lower urinary tract symptoms.
The Endocrine Society recommends that every newborn be screened for CAH, and positive results be followed up with confirmatory tests. The guideline also outlines treatment recommendations, including minimizing glucocorticoid dosage and considering patients' quality of life.
Researchers analyzed 12 focal nodular hyperplasia (FNH) lesions and found polyclonal nature with no loss of heterozygosity in most cases, contrasting with 40% monoclonality in altered hepatocytes. This study provides an approach for differential diagnosis and may lead to further understanding of early human hepatocarcinogenesis.
Scientists have identified genetic mutations on chromosome 17q24.2-q24.3 as responsible for Congenital Generalized Hypertrichosis Terminalis (CGHT), a rare condition characterized by excessive hair growth and facial distortion. The discovery provides new insight into the molecular mechanisms underlying this condition.
Researchers found that tadalafil improved detrusor pressure and bladder function in men with BPH-LUTS. The study also showed a significant reduction in obstructed patients after treatment with tadalafil.
Mayo Clinic researchers found that young women with atypical hyperplasia had a relative risk of developing breast cancer almost six times greater than those without BBD. A strong family history of breast cancer slightly increased the risk in two other forms of benign breast disease, but only marginally.
A recent study published in the Journal of Clinical Oncology found that women with atypia in their breast tissue are nearly eight times more likely to develop breast cancer. The study, led by Mayo Clinic, improved risk prediction by taking into account age at diagnosis and multiple sites of atypical hyperplasia.
A study by Mayo Clinic researchers found that men who took nonsteroidal anti-inflammatory drugs (NSAIDs) had a 50 percent lower risk of developing an enlarged prostate and a 35 percent lower risk of moderate to severe urinary symptoms compared to non-users.
Researchers found Botox injections to improve urinary tract symptoms and quality of life in men with enlarged prostates. The treatment reduced prostate size through apoptosis, improving urine flow and decreasing residual urine.
A recent study found that pretreating vein grafts with edifoligide did not prevent graft failure in coronary artery bypass surgery, despite its potential to inhibit neointimal hyperplasia. The study included 3,014 patients and demonstrated the effectiveness of targeted drug delivery to specific tissues or organs.
A University of Pittsburgh study shows Botox injections significantly reduce irritative symptoms and improve quality of life index by 62.3% and 56.5% respectively. Patients experienced increased flow rate and decreased residual urine without significant side effects.
A systematic review found that diagnostic test accuracy is underestimated when results are verified after a delay, with an average underestimation of 74%.
Researchers found that exposing rats to low levels of carbon monoxide significantly reduced intimal hyperplasia and leukocyte accumulation, indicating a protective effect against arteriosclerosis. The study suggests potential therapeutic benefits for treating vascular diseases.
Women with atypical lobular hyperplasia are three times more likely to develop invasive breast cancer, often on the same side as the atypia. The study challenges current beliefs that risk is equal in both breasts after a diagnosis of this condition.
A study of 33,344 participants found that higher dietary energy intake was associated with a greater risk of benign prostate disease. Additionally, high protein intake, especially from animal sources, and certain polyunsaturated fats increased the risk. The authors suggest that dietary factors may contribute to the development of BPH.
A study by NHLBI scientists has found a strong association between prior CMV infection and higher rates of restenosis after coronary angioplasty. The research suggests that predicting patients at risk of restenosis may lead to the use of bypass surgery instead of angioplasty.